MediMix Oncology
  • Home
  • Congresses
    • 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
Browse Tag

What’s new doc?

78 Articles
Breast Cancer

Episode 8: The DATA trial and the GIM trial: how to decide on extended endocrine therapy in Postmenopausal Breast Cancer Patients

9 November 2023
Breast Cancer

Episode 7: IMpassion031 at ESMO BREAST 2023

2 November 2023
Breast Cancer

Episode 6: The SOFT trial: 12-Year Outcomes for Adjuvant Endocrine Therapy in Premenopausal Breast Cancer Patients

19 October 2023
Breast Cancer

Episode 5: Unveiling Insights from the PALMIRA Trial: Continuing Palbociclib Beyond Progression in Metastatic Breast Cancer

12 October 2023
Breast Cancer

Episode 4: Critical Analysis of Oxford’s Controversial Meta-Analysis on Anthracyclines in Breast Cancer

5 October 2023
Breast Cancer

Episode 3: The SONIA Trial – First vs. Second-Line CDK4/6 Inhibition

28 September 2023
Breast Cancer

Episode 2: The POSITIVE trial

21 September 2023
Breast Cancer

Episode 1: The NATALEE trial

14 September 2023
« Previous 1 … 6 7 8

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Congresses
    • 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok